» Articles » PMID: 18447637

Conversion Potential of Marrow Cells into Lung Cells Fluctuates with Cytokine-induced Cell Cycle

Overview
Journal Stem Cells Dev
Date 2008 May 2
PMID 18447637
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Green fluorescent protein (GFP)-labeled marrow cells transplanted into lethally irradiated mice can be detected in the lungs of transplanted mice and have been shown to express lung-specific proteins while lacking the expression of hematopoietic markers. We have studied marrow cells induced to transit the cell cycle by exposure to interleukin-3 (IL-3), IL-6, IL-11, and Steel factor at different times of culture corresponding to different phases of cell cycle. We have found that marrow cells at the G(1)/S interface of the cell cycle have a three-fold increase in cells that assume a nonhematopoietic or pulmonary epithelial cell phenotype and that this increase is no longer seen in late S/G(2). These cells have been characterized as GFP(+) CD45(-) and GFP(+) cytokeratin(+). Thus, marrow cells with the capacity to convert into cells with a lung phenotype after transplantation show a reversible increase with cytokine-induced cell cycle transit. Previous studies have shown that the phenotype of bone marrow stem cells fluctuates reversibly as these cells traverse the cell cycle, leading to a continuum model of stem cell regulation. The present study indicates that marrow stem cell production of nonhematopoietic cells also fluctuates on a continuum.

Citing Articles

The universal stem cell.

Quesenberry P, Wen S, Goldberg L, Dooner M Leukemia. 2022; 36(12):2784-2792.

PMID: 36307485 PMC: 9712109. DOI: 10.1038/s41375-022-01715-w.


HSCs transdifferentiate primarily to pneumonocytes in radiation-induced lung damage repair.

Li L, Zhang S, Ge C, Ji L, Lv Y, Zhao C Aging (Albany NY). 2021; 13(6):8335-8354.

PMID: 33686967 PMC: 8034935. DOI: 10.18632/aging.202644.


Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives.

Abreu S, Lopes-Pacheco M, Weiss D, Rocco P Front Cell Dev Biol. 2021; 9:600711.

PMID: 33659247 PMC: 7917181. DOI: 10.3389/fcell.2021.600711.


Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke.

Li Y, Cheng Q, Hu G, Deng T, Wang Q, Zhou J Exp Ther Med. 2018; 15(5):4067-4079.

PMID: 29725359 PMC: 5920496. DOI: 10.3892/etm.2018.5993.


Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?.

Abreu S, Weiss D, Rocco P Stem Cell Res Ther. 2016; 7(1):53.

PMID: 27075363 PMC: 4831172. DOI: 10.1186/s13287-016-0317-0.